The Effect of Blood Group Types on Covid-19 Infection in Diabetic Patients | [Journal of Pioneering Medical Sciences • 2024]

Author(s):

1. Adawia Fadhil Abbas Alzubaidi: University of Diyala / College of Education of Pure Science / Biology/Microbiology/, Iraq

2. Afak Rasheed Salman Zaidi: University of Diyala / College of Education of Pure Science / Biology/Microbiology/, Iraq

3. Ali Abbas Ali: University of Diyala / College of Education of Pure Science / Biology/Microbiology/, Iraq

Abstract:

Background: A pandemic classification for COVID-19 was later issued. The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was the cause of it. It spreads quickly and can result in severe respiratory failure at an early stage. Clinical research has demonstrated that the risk of infection is increased by both aging and chronic conditions. As such, blood group effects on the COVID-19 infection and its progression remain unknown. Aim: This study investigates possible relationships between patient blood group types, risk of SARS-CoV-2 infection, and clinical outcomes in COVID-19 in diabetic patients. Methodology: Age (41-60) was shown to be the age group most susceptible to infection with the SARS-COVID-19 virus, according to a statistical analysis of data from 90 individuals infected with COVID-19. Based on gender, the findings indicated that women had a greater incidence of diabetes than men did, with women having a 46% incidence of diabetes and men having a 44% infection rate. The blood types A and O were the most prevalent. According to the results of the current investigation, blood type O+ individuals had a higher prevalence of diabetes than blood type O-individuals. Based on gender, the findings indicated that women had a greater incidence of diabetes than men did, with women having a 46% incidence of diabetes and men having a 44% infection rate. Results: The results of the present study suggest that while blood group A might have a role in increased susceptibility to COVID-19 infection, blood group O might be somewhat protective. However, blood group type does not seem to influence clinical outcomes once infected.

Page(s): 1-5

DOI: 10.61091/jpms202413501

Published: Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 5, Year: 2024

Keywords:

COVID19 , SARSCoV2 , Blood groups , Covid19 , diabetes militance

References:

[1] Xu X.,Chen P.,Wang J.,Feng J.,Zhou H.,Li X.,Hao P. .2020 .Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 63 : 457-460.

[2] Kleine-Weber H.,Elzayat M. T.,Wang L.,Graham B. S.,Müller M. A.,Drosten C.,Hoffmann M. .2019 .Mutations in the spike protein of Middle East respiratory syndrome coronavirus transmitted in Korea increase resistance to antibody-mediated neutralization. Journal of virology, 93(2) : 10-1128.

[3] Lu R.,Zhao X.,Li J.,Niu P.,Yang B.,Wu H.,Tan W. .2020 .Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224) : 565-574.

[4] Wang M.,Cao R.,Yang L.,Liu X.,Xu J.,Xiao M.,G. M. .2020 .Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3) : 269-271.

[5] Wrapp D.,Wang N.,Corbett K. S.,Goldsmith J. A.,Hsieh C. L.,Abiona O.,McLellan J. S. .2020 .Cryo-EM structure of the 2019- nCoV spike in the prefusion conformation. Science, 367(6483) : 1260-1263.

[6] Critchley J. A.,Carey I. M.,Harris T.,DeWilde S.,Hosking F. J.,Cook D. G. .2018 .Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care, 41(10) : 2127-2135.

[7] Luk A. O. Y.,Lau E. S. H.,Cheung K. K. T.,Kong A. P. S.,Ozaki R.,Chow F. C. C.,So W. Y.,Chan J. C. N. .2017 .Glycaemia control and the risk of hospitalisation for infection in patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetes/metabolism Research and Reviews, 33(8) : .

[8] Carey I. M.,Critchley J. A.,DeWilde S.,Harris T.,Hosking F. J.,Cook D. G. .2018 .Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care, 41(3) : 513-521.

[9] Luk A. O.,Wu H.,Lau E. S.,Yang A.,So A.,Chow E.,Chan J. C. .2001 .a retrospective study. Diabetologia, 64 : 109-118.

[10] Li S.,Wang J.,Li B.,Liu X.,Y. X. .2019 .Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study. Diabetes & Metabolism Journal, 43(3) : 319-341.

[11] Carey I. M.,Critchley J. A.,DeWilde S.,Harris T.,Hosking F. J.,Cook D. G. .2018 .Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care, 41(3) : 513-521.

[12] McDonald H. I.,Nitsch D.,Millett E. R. C.,Sinclair A.,Thomas S. L. .2014 .New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabetic Medicine, 31(5) : 606-614.

[13] Farshori M. P. Q.,Al-Wakid I. H.,Ibrahim I. K. A.,ALShammari A. F.,Alduejieman M.,Almhanaa A. M.,Al-Muzaini A. Y. .2016 .Distribution of ABO and Rhesus (Rh) blood group antigens in male type 2 diabetes mellitus patients in Hail region of Saudi Arabia: High incidences of diabetes mellitus in males with B+ blood type. Integr Obesity Diabetes, 2(3) : 233-238.

[14] Carey I. M.,Critchley J. A.,DeWilde S.,Harris T.,Hosking F. J.,Cook D. G. .2018 .Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care, 41(3) : 513-521.

[15] Critchley J. A.,Carey I. M.,Harris T.,DeWilde S.,Hosking F. J.,Cook D. G. .2018 .Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes care, 41(10) : 2127-2135.

[16] Li J.,Wang X.,Chen J.,Cai Y.,Deng A.,Yang M. .2020 .Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. British Journal of Haematology, 190(1) : 24-27.

[17] Barnkob M. B.,Pottegård A.,Støvring H.,Haunstrup T. M.,Homburg K.,Larsen R.,Barington T. .2020 .Reduced prevalence of SARSCoV-2 infection in ABO blood group O. Blood Advances, 4(20) : 4990-4993.

[18] Zietz M.,Zucker J.,Tatonetti N. P. .2020 .Associations between blood type and COVID-19 infection, intubation, and death. Nature Communications, 11(1) : 5761.

[19] Verbeke R.,Lentacker I.,De Smedt S. C.,Dewitte H. .2021 .The dawn of mRNA vaccines:. The COVID-19 case. Journal of Controlled Release, 333 : 511-520.

[20] Dai X. .2020 .ABO blood group is vulnerable to severe COVID-19 and cardiovascular disease. Eur J Ex Cardiol., 27 : 1436-1437.

Citations

Downloads

Views